Trump/Cook, Nissan weakness, more tariffs and gold - what’s moving markets
Healthcare Realty Trust Inc. (NYSE:HR) Director Thomas N. Bohjalian recently acquired shares in the company, according to a filing with the Securities and Exchange Commission. On May 13, Bohjalian purchased 2,500 shares of common stock at an average price of $14.71 per share, with the transaction amounting to a total of $36,775. The purchase comes as the stock trades near its 52-week low of $14.53, with InvestingPro data showing the company maintains an attractive 8.43% dividend yield.
Following this acquisition, Bohjalian’s direct ownership of Healthcare Realty Trust’s common stock increased to 56,502 shares. The transaction was executed in multiple trades, with prices ranging from $14.70 to $14.72 per share. For deeper insights into insider trading patterns and comprehensive analysis, InvestingPro subscribers can access detailed research reports covering this $5.24 billion healthcare REIT.
This purchase reflects Bohjalian’s continued investment in Healthcare Realty Trust, a real estate investment trust (REIT) that focuses on owning, managing, and developing properties associated with the delivery of healthcare services. The company has maintained consistent dividend payments for 33 consecutive years, demonstrating a strong commitment to shareholder returns.
In other recent news, Healthcare Realty Trust Incorporated reported its first-quarter 2025 earnings, revealing a loss per share of -$0.13, which fell short of analyst expectations of -$0.07. Despite this earnings miss, the company slightly exceeded revenue forecasts, reporting $298.98 million against an anticipated $298.56 million. Healthcare Realty reaffirmed its full-year normalized funds from operations (FFO) per share guidance of $1.56 to $1.60. The company is focusing on leasing, portfolio optimization, and balance sheet management, with plans to dispose of $400-500 million in assets. Healthcare Realty’s leadership saw a change with Peter Scott stepping in as the new President and CEO. The company continues to emphasize its strategic focus on outpatient medical real estate, maintaining strong tenant relationships and targeting growth in high-demand markets. Despite challenges, the firm reported a same-store occupancy rate of 89.3%, with plans to improve this figure. Analyst firms such as Wedbush and BMO Capital Markets have engaged with the company, reflecting ongoing interest and scrutiny from the investment community.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.